Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy.

International journal of radiation oncology, biology, physics - 1 Mar 2020

Mohammadi Homan, Prince Austin, Figura Nicholas B, Peacock Jeffrey S, Fernandez Daniel C, Montejo Michael E, Chon Hye Sook, Wenham Robert M, Eschrich Steven A, Torres-Roca Javier F, Ahmed Kamran A

Abstract excerpt

PURPOSE: Variability exists in the adjuvant treatment for endometrial cancer (EC) based on surgical pathology and institutional preference. The radiosensitivity index (RSI) is a previously validated multigene expression index that estimates tumor radiosensitivity. We evaluate RSI as a genomic predictor for pelvic failure (PF) in EC patients treated with adjuvant radiation therapy (RT). METHODS AND MATERIALS:...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial Neoplasms
Share to Hysterectomy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymph Node Excision

Share to Multivariate Analysis

Share to Neoplasm Recurrence, Local

Share to Progression-Free Survival

Share to Radiation Tolerance

Share to Radiotherapy, Adjuvant

Source

Open in PubMed Open full text

Identifiers

PMID: 31759077
DOI: 10.1016/j.ijrobp.2019.11.013
PMCID: PMC7050205

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Using the Radiosensitivity Index (RSI) to Predict Pelvic Failure in Endometrial Cancer Treated With Adjuvant Radiation Therapy.PMID 31759077Read ↗

Combination of radiosensitivity index and PD-L1 status predicts overall survival of endometrial cancer patients treated with radiotherapy: A study based on TCGA dataSemantic proximity Read ↗

A gene expression platform to predict benefit from adjuvant external beam radiation in resected non-small cell lung cancerSemantic proximity Read ↗

Radiosensitivity is associated with antitumor immunity in estrogen receptor-negative breast cancerSemantic proximity Read ↗

ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.Semantic proximity Read ↗

Development and Validation of a Novel Radiosensitivity Signature in Human Breast CancerSemantic proximity Read ↗

Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapySemantic proximity Read ↗

Variant-to-Biomarker Integration and Mechanistic Validation Identify CES1 as a Copy Number-Linked Predictor of Radiotherapy Response in Rectal Cancer.Semantic proximity Read ↗

Adjuvant treatment in early-stage endometrial cancer: context-dependent impact of somatic CTNNB1 mutation on recurrence-free survival.Semantic proximity Read ↗

Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cellsSemantic proximity Read ↗

DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to ChemotherapySemantic proximity Read ↗

Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiationSemantic proximity Read ↗

Molecular and histopathologic predictors of distant failure in endometrial cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.